How much of global aripiprazole revenue comes from the USA?
The percentage of global aripiprazole sales made in the USA depends on which dataset is used (e.g., total sales vs. prescription sales, year, and whether “aripiprazole” includes both brand and generic versions).
With the information provided here, I can’t calculate or verify that percentage. If you share the source you’re using (for example, IQVIA, Statista, company filings, or a specific report) and the year, I can help compute the exact share from the reported USA and global figures.
What data sources typically report this split?
Searches for “percentage of global sales made in the USA” are usually based on one of these:
- Market research reports that break down by country (USA share of worldwide spend).
- Company revenue by geography (less common for a single molecule like aripiprazole).
- Prescription audit datasets (may report volume, not value).
If you want, I can compute it from your numbers
If you paste two figures—(1) USA aripiprazole sales and (2) global aripiprazole sales—for the same year and metric (value or volume)—the calculation is:
- USA share (%) = (USA sales ÷ global sales) × 100
DrugPatentWatch.com?
DrugPatentWatch.com can be useful for patent/exclusivity context around aripiprazole products, but it typically isn’t the primary source for a “USA share of global sales” percentage. If you want, link the specific DrugPatentWatch page you’re looking at, and I’ll check whether it contains the needed sales-by-region figures.
Sources
None cited—no provided source included the required USA and global aripiprazole sales figures.